RecruitingPhase 4NCT06972056
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Sponsor: Mayo Clinic
Philadelphia, PA · +36 more sites
Migraine clinical trials in Philadelphia, PA
12 recruiting migraine studies with a site in Philadelphia, PA.
RecruitingPhase 3NCT07674654
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Allentown, PA · Philadelphia, PA · Pittsburgh, PA · +110 more sites
RecruitingPhase 3NCT06810505
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Sponsor: AbbVie
Philadelphia, PA · Scottdale, PA · Smithfield, PA · +29 more sites
RecruitingPhase 3NCT05711394
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Sponsor: AbbVie
Philadelphia, PA · +41 more sites
RecruitingPhase 1NCT06995729
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
Sponsor: Pfizer
Philadelphia, PA · +13 more sites
RecruitingNot applicableNCT06735833
MMA Embolization for Refractory Chronic Migraine
Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
Philadelphia, PA · +7 more sites
RecruitingPhase 3NCT04649242
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Sponsor: Pfizer
Philadelphia, PA · +167 more sites
RecruitingPhase 3NCT04743141
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Sponsor: Pfizer
Philadelphia, PA · +113 more sites
RecruitingNot applicableNCT05889624
Responding With Evidence and Access for Childhood Headaches
Sponsor: Children's Hospital Medical Center, Cincinnati
Philadelphia, PA · +14 more sites
RecruitingPhase 3NCT05125302
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Sponsor: AbbVie
Philadelphia, PA · Scottdale, PA · Smithfield, PA · +122 more sites
RecruitingPhase 3NCT07645924
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Allentown, PA · Philadelphia, PA · Pittsburgh, PA · +110 more sites
RecruitingPhase 3NCT06641466
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Sponsor: Pfizer
Philadelphia, PA · +30 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.